SLIT: Implementation in Your Practice

Activity Description

Now that the FDA has approved the first sublingual immunotherapy (SLIT) products for use in the United States, allergist/immunologists have new options to consider when treating their patients who could benefit from allergen immunotherapy. This presentation - a recording of a symposium presented at the 2014 AAAAI Annual Meeting - provides an overview of the mechanisms of SLIT, a summary of the results of clinical trials with these new forms of immunotherapy, and a discussion of how to incorporate the administration of SLIT into an allergy/immunology practice.

Target audience: 


Allied Health Professionals working in allergy/immunology practices

Learning objectives: 
  1. Review how SLIT works.
  2. Discuss the results of pivotal SLIT clinical trials.
  3. Describe how to use SLIT in practice.
Credits & accreditation
  • 1.50 CE
    CE credit.
  • 1.25 CME
    CME credit.
  • 1.25 Attendance
    Attendance credit.
Faculty & disclosure


Desiree E.S. Larenas-Linnemann, MD FAAAAI

Michael S. Tankersley, MD FAAAAI


Stephen R. Durham, MA MD FRCP

Thomas B. Casale, MD FAAAAI

Linda Cox, MD FAAAAI

Additional information
Required hardware / software: 

Two most recent versions of Internet Explorer, Safari, Google Chrome, and Firefox with pop-ups enabled

Available credit: 
  • 1.50 CE
    CE credit.
  • 1.25 CME
    CME credit.
  • 1.25 Attendance
    Attendance credit.
Course opens: 
Course expires: 
Please login or register to take this course.